Long-term testosterone therapy does not increase risk of prostate cancer

25 noviembre 2014

Testosterone (T) therapy is routinely used in men with hypogonadism, a condition in which diminished function of the gonads occurs. Although there is no evidence that T therapy increases the risk of prostate cancer (PCa), there are still concerns and a paucity of long-term data. In a new study, investigators examined three parallel, prospective, ongoing, cumulative registry studies of over 1,000 men. Their analysis showed that long-term T therapy in hypogonadal men is safe and does not increase the risk of PCa.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/K_nCfhgN-7g/141125124908.htm

Volver